Design of a New < sup > 99m < /sup > Tc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR < sub > 4 < /sub > Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation

CONCLUSION: Therefore, the findings indicate this designed radioligand could be used as a potential SPECT imaging agent in highly proliferated CXCR4 receptor tumors.PMID:37921191 | DOI:10.2174/0118744710249305231017073022

Source: Current Radiopharmaceuticals - November 3, 2023 Category: Radiology Authors: Leila Hassanzadeh Mostafa Erfani Safura Jokar Marjan Shriatpanahi Source Type: research